J&J Will Extend Neuro Presence With $480 Million Micrus Acquisition

Johnson & Johnson's $480 million acquisition of Micrus Endovascular will expand its presence in the hemorrhagic stroke market and give the company a foothold in the high-promise ischemic stroke space